A trial of 15 men with stable CAD demonstrated that six weeks of supplementation with twenty billion CFUs of Lactobacillus plantarum induced favorable metabolic effects including downregulation of inflammation driven by IL-1β, TNF-a, and upregulation of regulatory T-cells (3). The gene discussed is TNF; the disease is coronary artery disorder.